Key points are not available for this paper at this time.
This economic evaluation found that the more than 1. 2 billion and increasing annual costs for ED and inpatient care of FNDs were similar to other investigation-intensive and pharmacologically demanding neurological disorders. Unnecessary investigations and iatrogenic harm inflate costs at the expense of necessary but neglected psychiatric and rehabilitative treatments.
Stephen et al. (Mon,) studied this question.